MAPKAPK2 and neoplasm: Drug inhibition of parental Ly2 tumors orthotopically implanted into immunocompetent mice with MK2 inhibitor PF-3644022 resulted in decreased tumor volume, reduced numbers of CTCs, and reduced lymph node and lung metastases.